Singleton, S. Parker http://orcid.org/0000-0002-7102-7820
Luppi, Andrea I. http://orcid.org/0000-0002-3461-6431
Carhart-Harris, Robin L.
Cruzat, Josephine http://orcid.org/0000-0002-3252-8657
Roseman, Leor
Nutt, David J. http://orcid.org/0000-0002-1286-1401
Deco, Gustavo http://orcid.org/0000-0002-8995-7583
Kringelbach, Morten L. http://orcid.org/0000-0002-3908-6898
Stamatakis, Emmanuel A. http://orcid.org/0000-0001-6955-9601
Kuceyeski, Amy http://orcid.org/0000-0002-5050-8342
Article History
Received: 17 June 2021
Accepted: 22 September 2022
First Online: 3 October 2022
Competing interests
: R.L.C.-H. is an advisor to Beckley Psytech, Entheon Biomedical, TRYP Therapeutics, Mydecine, Usona Institute, Synthesis Institute, Osmind, Maya Health, and Journey Collab. D.J.N. is an advisory to COMPASSPathways, Neural Therapeutics, and Algernon Pharmaceuticals. All other authors declare no competing interests.